U.S. flag

An official website of the United States government

NM_000531.6(OTC):c.988A>G (p.Arg330Gly) AND Ornithine carbamoyltransferase deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 9, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001857406.4

Allele description [Variation Report for NM_000531.6(OTC):c.988A>G (p.Arg330Gly)]

NM_000531.6(OTC):c.988A>G (p.Arg330Gly)

Gene:
OTC:ornithine transcarbamylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp11.4
Genomic location:
Preferred name:
NM_000531.6(OTC):c.988A>G (p.Arg330Gly)
HGVS:
  • NC_000023.11:g.38411982A>G
  • NG_008471.1:g.64500A>G
  • NM_000531.6:c.988A>GMANE SELECT
  • NP_000522.3:p.Arg330Gly
  • LRG_846t1:c.988A>G
  • LRG_846:g.64500A>G
  • LRG_846p1:p.Arg330Gly
  • NC_000023.10:g.38271235A>G
  • NM_000531.5:c.988A>G
  • P00480:p.Arg330Gly
Protein change:
R330G
Links:
UniProtKB: P00480#VAR_004939; dbSNP: rs72558478
NCBI 1000 Genomes Browser:
rs72558478
Molecular consequence:
  • NM_000531.6:c.988A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Ornithine carbamoyltransferase deficiency (OTCD)
Synonyms:
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; Ornithine transcarbamylase deficiency; OTC deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010703; MedGen: C0268542; Orphanet: 664; OMIM: 311250

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002240986Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 9, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of 'private' mutations in patients with ornithine transcarbamylase deficiency.

Tuchman M, Morizono H, Rajagopal BS, Plante RJ, Allewell NM.

J Inherit Metab Dis. 1997 Aug;20(4):525-7.

PubMed [citation]
PMID:
9266388

Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

McCullough BA, Yudkoff M, Batshaw ML, Wilson JM, Raper SE, Tuchman M.

Am J Med Genet. 2000 Aug 14;93(4):313-9.

PubMed [citation]
PMID:
10946359
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002240986.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. This variant has been observed in individual(s) with ornithine transcarbamylase deficiency (PMID: 9266388, 10946359, Invitae). ClinVar contains an entry for this variant (Variation ID: 97376). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with glycine at codon 330 of the OTC protein (p.Arg330Gly). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and glycine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024